Pharmaceutical Executive
In its campaign for Novartis Oncology's Femara, an aromatase inhibitor (AI), AgencyRx developed simple and haunting creative by keeping science as the focal point. "Its simplicity is very powerful. But at the same time, simplicity doesn't belittle it," says Michael Schreiber, managing partner, creative director. "It makes it that much more devastating."
THIS IS BREAST CANCER
AgencyRx
BRAND Femara CLIENT Novartis Oncology FROM LEFT: Michael Schreiber, managing partner, creative director, copy; Sarah Katz, art supervisor; Ralph Skorge, managing partner, creative director, art; Pamela Ringstrom, copy supervisor
In its campaign for Novartis Oncology's Femara, an aromatase inhibitor (AI), AgencyRx developed simple and haunting creative by keeping science as the focal point. "Its simplicity is very powerful. But at the same time, simplicity doesn't belittle it," says Michael Schreiber, managing partner, creative director. "It makes it that much more devastating."
The goal was to raise awareness about distant metastases and illustrate how cancer that originates in the breast can travel. "We wanted to make sure that doctors understood the nature of breast cancer and the importance of therapy that would reduce the risk of a distant recurrence," says Schreiber. "We created this very stark, attention-grabbing message."
The ad underscored Femara's unique benefits—a must to compete against the market leader in the category. Originally created as a one-time ad, "This is..." used iconic imagery to form the basis of a new global professional campaign for Femara. Aimee Roca, vice president, account supervisor, credits response of the Novartis Oncology team and physicians for the ad's global success.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.